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Which sounds more acceptable?
Marijuana or nabiximols?
(Royalty free via Unsplash)
STIGMA, LABELS, & SOCIAL VALIDITY
•Stigma is conveyed via labels (Link & Phelan, 2001)
• Survivors vs. victims (Papendick & Bohner, 2015)
• Noncitizens vs. illegal aliens (Rucker, Murphy, & Quintanilla, 2019)
• Marijuana cigarette vs. pill (Rudski, 2014)
• How do stigmatizing labels such as marijuana shape 
people’s attitudes toward its medical efficacy? (Wolf, 1978)

Variables & Hypotheses
• Labels: Marijuana, cannabis, THC, and nabiximols
• Context: Treating pain due to cancer (from JAMA, 2015)
• Seeing marijuana (vs. nabiximols) will decrease approval, 
increase preference for prohibitive policy, increase stigma, and 
increase moral conviction for views.
• MTurk (n = 138; U.S. 
only; $1.00 payment)
Measures
• Treatment approval (eight-item; a = .9)
This treatment is an acceptable treatment for cancer pain.
• Stigma (four-items; a = .8)
I would be ashamed to use marijuana to treat my cancer pain.
• Policy preference for medical cannabis (three-items; a = .8)
Marijuana should be legal OTC, prescribed, and for research.
• Moral conviction (one-item) extent feelings on marijuana 
reflect beliefs about fundamental right and wrong
• Political orientation (one-item; 1 = very lib. to 5 = very con.)
Pearson Correlation Matrix 
    Moral Conviction Stigma Approval Policy Preference 
Moral Conviction 
Pearson's r —       
p-value —       
Stigma 
Pearson's r 0.294 —     
p-value < .001 —     
Approval 
Pearson's r -0.029 -0.563 —   
p-value 0.736 < .001 —   
Policy 
Preference 
Pearson's r -0.071 -0.562 0.767 — 
p-value 0.408 < .001 < .001 — 
d = .37 p = .04d = .39 p = .03
Marijuana vs. Nabiximols (n = 63)
Overall model p = .9 [-.0277, .0164]]
Not as predicted







e = -.5 p < .001
Discussion
• General vs. medical lang. implications for treatment acceptability
• Should we evoke stigma? Under what conditions would it go away?
• Need more power (direct replication w/ at least 2x participants) 
to look at users and non-users accurately
• Examine other samples
• MTurk seems to have high acceptance for marijuana
• Less-accepting populations should be examined (i.e., physicians)
